Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) EBIT : $-0.27 Mil (TTM As of Nov. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings EBIT?

Cannabis Bioscience International Holdings's earnings before interest and taxes (EBIT) for the six months ended in Nov. 2023 was $-0.27 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Nov. 2023 was $-0.27 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Cannabis Bioscience International Holdings's annualized ROC % for the quarter that ended in Nov. 2023 was -176.32%. Cannabis Bioscience International Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Nov. 2023 was -653.66%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Cannabis Bioscience International Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Nov. 2023 was -3.46%.

Cannabis Bioscience International Holdings EBIT Historical Data

The historical data trend for Cannabis Bioscience International Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Bioscience International Holdings EBIT Chart

Cannabis Bioscience International Holdings Annual Data

Trend

Dec06

Dec07

May09

May10

May11

EBIT

-0.02

-0.06

11.07

-12.42

14.57

Cannabis Bioscience International Holdings Semi-Annual Data
	Dec06	Jun07	Dec07	Jun08	May09	Nov09	May10	Nov10	May11	Nov11	Nov22	Nov23
EBIT	Get a 7-Day Free Trial							10.08	4.49	7.60	-0.38	-0.27

Competitive Comparison of Cannabis Bioscience International Holdings's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannabis Bioscience International Holdings's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Bioscience International Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cannabis Bioscience International Holdings's EV-to-EBIT falls into.

Cannabis Bioscience International Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Nov. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.27 Mil.

Cannabis Bioscience International Holdings (OTCPK:CBIH) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Cannabis Bioscience International Holdings's annualized ROC % for the quarter that ended in Nov. 2023 is calculated as:

	ROC % (Q: Nov. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Nov. 2022 )	+	Invested Capital (Q: Nov. 2023 ))	/ count )
=	-0.536 * ( 1 - 0% )	/	( (0	+	0.304)	/ 1 )
=	-0.536	/	0.304
=	-176.32 %

where

	Invested Capital		(Q: Nov. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0	-	0	-	( 0	-	max(0, 0	-	0	+	0	))
=	0

	Invested Capital		(Q: Nov. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.102	-	0.438	-	( 0	-	max(0, 0.66	-	0.02	+	0	))
=	0.304

Note: The Operating Income data used here is two times the semi-annual (Nov. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Cannabis Bioscience International Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Nov. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Nov. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Nov. 2022		Q: Nov. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-0.536	/	( ( (0 + max(0, 0))	+	(0.082 + max(-0.418, 0)) )	/	1 )
=	-0.536	/	( ( 0	+	0.082 )	/	1 )
=	-0.536	/	0.082
=	-653.66 %

where Working Capital is:

	Working Capital		(Q: Nov. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0)	-	(0	+	0	+	0)
=	0

	Working Capital		(Q: Nov. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.019	+	0	+	0.001)	-	(0.438	+	0	+	0)
=	-0.418

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Nov. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Cannabis Bioscience International Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Nov. 2023 )
	=	-0.268	/	7.755
	=	-3.46 %

Cannabis Bioscience International Holdings EBIT Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

6201 Bonhomme Road, Suite 466S, Houston, TX, USA, 77036

Website

https://www.cbih.net

Cannabis Bioscience International Holdings Inc is engaged in providing educational systems relating to cannabis and services in therapeutic areas. of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. The Company generates revenue from multiple streams, namely, clinical trials, consulting fees, video courses, seminars, royalties, and merchandise sales. The company generates the majority of its revenue from clinical trials.